Bioverativ U.s. LLC. Revenue, Growth & Competitor Profile

DBA Bioverativ Inc.
DBA BIOVERATIV THERAPEUTICS, INC.

Company Profile & Annual Report for Bioverativ U.s. LLC.

Access the complete profile.

Bioverativ U.s. LLC. Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	225 2nd Ave Waltham, MA 02451

Note: Revenues for privately held companies are statistical evaluations.


Bioverativ U.s. LLC.'s Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Bioverativ U.s. LLC.'s annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Bioverativ U.s. LLC. is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Bioverativ U.s. LLC. Annual Revenue and Growth Rate

Bioverativ U.s. LLC.	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Bioverativ U.s. LLC.'s revenues are gauged from an analysis of company filings.

Bioverativ U.s. LLC.'s Income Statement (based on Industry Averages)

Bioverativ U.s. LLC. P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Bioverativ U.s. LLC. is developing and marketing. Bioverativ U.s. LLC. doesn't have any recent trademark applications, indicating Bioverativ U.s. LLC. is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ALTUVOCT Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of hemophilia; pharmaceutical products for the prevention and treatment of diseases in the immunology field	05/10/2022
ALTUVIO Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of hemophilia; pharmaceutical products for the prevention and treatment of immunological diseases	10/06/2021
FACZEED Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of hemophilia; pharmaceutical products for the prevention and treatment of immunological diseases	03/23/2021

See all trademarks and details in the Full Report.

Market Share of Bioverativ U.s. LLC.'s Largest Competitors

A competitive analysis shows these companies are in the same general field as Bioverativ U.s. LLC., even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Bioverativ U.s. LLC.. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REPLIGEN	Waltham, Massachusetts,united States, MA	100
APELLIS PHARMACEUTICALS	Waltham, MA	67
CUBIST PHARMACEUTICALS	Lexington, MA	59
BIOVERATIV U.S. LLC.	Waltham, MA	58
ABCAM	Waltham, MA	29
KARYOPHARM THERAPEUTICS	Newton, MA	25

Future Competition: Bioverativ U.s. LLC.'s Fastest Growing Competitors

These companies are in the same general field as Bioverativ U.s. LLC. and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)